Who Paid My Doc
Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- M17-238 NCT03922607
- M17-238 NCT000000NA
- M17-239 NCT000000NA
- M17-327 NCT03639194
- M17-380 - A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis (Start Up) No ClinicalTrials.gov identifier reported
- M1774 in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301) NCT04170153
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M184V/I Viremic Case Study Series No ClinicalTrials.gov identifier reported
- M18-764 NCT000000NA
- M18-803 NCT03873493
- M18-809 No ClinicalTrials.gov identifier reported
- M18-809 NCT000000NA
- M18-868 - A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No ClinicalTrials.gov identifier reported
- M18-891 NCT03607422
- M18-891 - A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) No ClinicalTrials.gov identifier reported
- M18-918 NCT03737851
- M18-969 NCT04333576
- M18-969 - Study of Oral Elagolix Tablets in Combination With Combined Oral Contraceptive Capsules Tablets to Assess Dysmenorrhea Response in Adult Female Participants With Endometriosis and Associated Moderate to Severe Pain No ClinicalTrials.gov identifier reported
- M19-034 NCT000000NA
- M19-034 No ClinicalTrials.gov identifier reported
- M19-037 NCT03893955
- M19-037 - A Study to Determine the Safety Tolerability Pharmacokinetics and Preliminary Efficacy of ABBV-927 With ABBV-368 Budigalimab (ABBV-181) and or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors No ClinicalTrials.gov identifier reported
- M19-044 - A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo (Viti-Up) No ClinicalTrials.gov identifier reported
- M19-044 Rinvoq Phase 3 Vitiligo NCT06118411
- M19-063 NCT04161885
- M19-063 - A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML) No ClinicalTrials.gov identifier reported
- M19-072 NCT03941964
- M19-098 No ClinicalTrials.gov identifier reported
- M19-116 No ClinicalTrials.gov identifier reported